Короткий опис (реферат):
Obesity is associated with profound alterations in the composition and function of
the gut microbiota that extend far beyond the gastrointestinal tract. Accumulating
evidence indicates that obesity-associated gut dysbiosis influences intestinal
barrier integrity, immune regulation, microbial metabolism, and systemic metabolic
homeostasis through interconnected biological mechanisms. These alterations
contribute to the development of chronic metabolic disorders affecting several
organ systems. This review summarizes current knowledge regarding the host–
microbiome interactions linking obesity-associated gut dysbiosis with metabolic
dysfunction. Particular attention is given to the sequential interactions between
microbial ecosystem remodeling, impaired intestinal barrier function, chronic low-
grade inflammation, and metabolic disturbances that collectively promote obesity-
associated diseases. Rather than focusing exclusively on liver pathology, metabolic
dysfunction-associated steatotic liver disease is presented as one of the best-
characterized clinical models demonstrating how disturbances originating within the
gut microbiome evolve into systemic metabolic disease. Finally, emerging therapeutic
strategies targeting the gut–microbiome axis are discussed, with emphasis on
restoration of microbial homeostasis and early intervention aimed at interrupting
pathophysiological progression before irreversible metabolic complications develop.
These approaches may contribute to preventing or attenuating obesity-associated
metabolic complications.